Abstract bekijken

Deze abstract is toegekend aan sessie AOB FP
TitelFirst year Experience with Ruthenium Brachytherapy in ocular melanoma @ UZLeuven.
DoelTo evaluate the procedure and technique for ruthenium brachytherapy in ocular melanoma patients after the introduction in a tertiary care centre in February 2018.
MethodesRetrospective analysis of our database and review of the detailed literature on ruthenium brachytherapy in ocular melanoma. Our department has tree ruthenium plaques (CCA, CCB and COB) that can be applied for different tumour sizes.
ResultatenBetween February and September 2018, 20 patients were treated with ruthenium brachytherapy: 4 conjunctival melanomas, 1 iris melanoma and 15 uveal melanomas. Application time differs from 6.8 to 226.1 hours, for a top dose of 100 Gy. In one patient a temporary vitreous haemorrhage occurred after the application (juxtapapillary tumour). In 2 patients a diplopia was found up to 1 month after the application. Taking into account the limited follow-up, no recurrences occurred.
ConclusieRuthenium brachytherapy is a good and safe procedure for the treatment of ocular melanoma.
BelangenverstrengelingNee
Auteur 1
NaamMISSOTTEN
InitialenGS
InstituutDept Ophthalmology, Catholic University Hospitals Leuven
StadLeuven
Auteur 2
NaamVan Ginderdeuren
InitialenR
InstituutDept Ophthalmology and Anatomopathology, Catholic University Hospitals Leuven
StadLeuven
Auteur 3
NaamVan Limbergen
InitialenE
InstituutDept Radiotherapy, Catholic University Hospitals Leuven
StadLeuven
Auteur 4
NaamVan Calster
InitialenJ
InstituutDept Ophthalmology, Catholic University Hospitals Leuven
StadLeuven
top ^